Further molecular characterization and stability of the live oral attenuated cholera vaccine strain CVD103-HgR

By Favre D.   Struck M.-M.   Cryz S.J.   Viret J.-F.  

Vaccine, Vol. 14, Iss. 6, 1996-04 ,pp. : 526-531

Elsevier

Access to resources Recommend Favorite

Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area

By Richie E.E.   Punjabi N.H.N.H.   Sidharta Y.Y.   Peetosutan K.K.   Sukandar M.M.   Wasserman S.S.S.S.   Lesmana M.M.   Wangsasaputra F.F.   Pandam S.S.   Levine M.M.M.M.   O'Hanley P.P.   Cryz S.J.S.J.   Simanjuntak C.H.C.H.  

Vaccine, Vol. 18, Iss. 22, 2000-05 ,pp. : 2399-2410

Elsevier

Access to resources Recommend Favorite

A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens

By Galen J.E.   Gomez-Duarte O.G.   Losonsky G.A.   Halpern J.L.   Lauderbaugh C.S.   Kaintuck S.   Reymann M.K.   Levine M.M.  

Vaccine, Vol. 15, Iss. 6, 1997-04 ,pp. : 700-708

Elsevier

Access to resources Recommend Favorite

Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors

By Pasetti M.F.   Levine M.M.   Sztein M.B.  

Vaccine, Vol. 21, Iss. 5, 2003-01 ,pp. : 401-418

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers

By Bumann D.   Metzger W.G.   Mansouri E.   Palme O.   Wendland M.   Hurwitz R.   Haas G.   Aebischer T.   von Specht B.-U.   Meyer T.F.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 845-852

Elsevier

Access to resources Recommend Favorite